Latest Insider Transactions at Verve Therapeutics, Inc. (VERV)
This section provides a real-time view of insider transactions for Verve Therapeutics, Inc. (VERV). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Verve Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Verve Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 04
2024
|
Sekar Kathiresan Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
30,000
+21.28%
|
-
|
|
Dec 04
2024
|
Sekar Kathiresan Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
30,000
-8.49%
|
-
|
|
Dec 02
2024
|
Allison Dorval Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
555
-9.35%
|
$2,775
$5.64 P/Share
|
|
Nov 29
2024
|
Allison Dorval Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,875
+24.01%
|
-
|
|
Jun 28
2024
|
Sekar Kathiresan Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+7.87%
|
$60,000
$2.87 P/Share
|
|
May 14
2024
|
Andrew D. Ashe |
BUY
Open market or private purchase
|
Direct |
76,000
+18.16%
|
$456,000
$6.26 P/Share
|
|
Apr 02
2024
|
Joan Nickerson Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
1,514
-14.88%
|
$12,112
$8.24 P/Share
|
|
Apr 01
2024
|
Joan Nickerson Chief Administrative Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,315
+24.58%
|
-
|
|
Dec 01
2023
|
Krishna Yeshwant |
BUY
Open market or private purchase
|
Indirect |
1,800,000
+50.0%
|
$18,000,000
$10.0 P/Share
|
|
Nov 29
2023
|
Allison Dorval Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
554
-12.01%
|
$6,094
$11.45 P/Share
|
|
Nov 29
2023
|
Allison Dorval Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,875
+28.9%
|
-
|
|
Dec 14
2022
|
Andrew Bellinger Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
36,000
+45.78%
|
$72,000
$2.87 P/Share
|
|
Dec 01
2022
|
Andrew Bellinger Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
865
-11.54%
|
$19,030
$22.95 P/Share
|
|
Nov 29
2022
|
Allison Dorval Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
554
-20.22%
|
$12,188
$22.1 P/Share
|
|
Nov 29
2022
|
Allison Dorval Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,875
+40.63%
|
-
|
|
Nov 04
2022
|
Krishna Yeshwant |
SELL
Open market or private sale
|
Indirect |
48,583
-0.38%
|
$1,554,656
$32.0 P/Share
|
|
Nov 04
2022
|
Krishna Yeshwant |
SELL
Other acquisition or disposition
|
Indirect |
48,583
-0.79%
|
-
|
|
Nov 04
2022
|
Gv 2017 Gp, L.L.C. |
SELL
Open market or private sale
|
Indirect |
97,166
-45.37%
|
$3,109,312
$32.0 P/Share
|
|
Nov 04
2022
|
Gv 2017 Gp, L.L.C. |
SELL
Other acquisition or disposition
|
Indirect |
48,583
-0.79%
|
-
|
|
Nov 03
2022
|
Krishna Yeshwant |
SELL
Open market or private sale
|
Indirect |
49,568
-0.38%
|
$1,635,744
$33.1 P/Share
|
|
Nov 03
2022
|
Krishna Yeshwant |
SELL
Other acquisition or disposition
|
Indirect |
49,569
-0.8%
|
-
|
|
Nov 03
2022
|
Gv 2017 Gp, L.L.C. |
SELL
Open market or private sale
|
Indirect |
99,137
-39.94%
|
$3,271,521
$33.1 P/Share
|
|
Nov 03
2022
|
Gv 2017 Gp, L.L.C. |
SELL
Other acquisition or disposition
|
Indirect |
49,569
-0.8%
|
-
|
|
Nov 02
2022
|
Krishna Yeshwant |
SELL
Open market or private sale
|
Indirect |
28,652
-0.22%
|
$1,002,820
$35.94 P/Share
|
|
Nov 02
2022
|
Krishna Yeshwant |
SELL
Other acquisition or disposition
|
Indirect |
28,651
-0.46%
|
-
|
|
Nov 02
2022
|
Gv 2017 Gp, L.L.C. |
SELL
Open market or private sale
|
Indirect |
57,303
-31.17%
|
$2,005,605
$35.94 P/Share
|
|
Nov 02
2022
|
Gv 2017 Gp, L.L.C. |
SELL
Other acquisition or disposition
|
Indirect |
28,651
-0.46%
|
-
|
|
Nov 01
2022
|
Krishna Yeshwant |
SELL
Open market or private sale
|
Indirect |
31,963
-0.24%
|
$1,182,631
$37.72 P/Share
|
|
Nov 01
2022
|
Krishna Yeshwant |
SELL
Other acquisition or disposition
|
Indirect |
31,963
-0.51%
|
-
|
|
Nov 01
2022
|
Gv 2017 Gp, L.L.C. |
SELL
Open market or private sale
|
Indirect |
63,926
-47.1%
|
$2,365,262
$37.72 P/Share
|
|
Nov 01
2022
|
Gv 2017 Gp, L.L.C. |
SELL
Other acquisition or disposition
|
Indirect |
31,963
-0.51%
|
-
|
|
Oct 31
2022
|
Krishna Yeshwant |
SELL
Open market or private sale
|
Indirect |
53,696
-0.3%
|
$2,094,144
$39.41 P/Share
|
|
Oct 31
2022
|
Krishna Yeshwant |
SELL
Other acquisition or disposition
|
Indirect |
53,697
-0.85%
|
-
|
|
Oct 31
2022
|
Gv 2017 Gp, L.L.C. |
SELL
Open market or private sale
|
Indirect |
107,393
-40.22%
|
$4,188,327
$39.41 P/Share
|
|
Oct 31
2022
|
Gv 2017 Gp, L.L.C. |
SELL
Other acquisition or disposition
|
Indirect |
53,697
-0.85%
|
-
|
|
Oct 28
2022
|
Andrew Bellinger Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-60.14%
|
$390,000
$39.9 P/Share
|
|
Oct 28
2022
|
Andrew Bellinger Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+37.55%
|
$10,000
$1.48 P/Share
|
|
Oct 03
2022
|
Sekar Kathiresan Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-4.73%
|
$1,700,000
$34.04 P/Share
|
|
Oct 03
2022
|
Sekar Kathiresan Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+11.97%
|
$50,000
$1.39 P/Share
|
|
Sep 23
2022
|
Andrew Bellinger Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
60,000
-50.81%
|
$2,100,000
$35.4 P/Share
|
|
Sep 23
2022
|
Andrew Bellinger Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
60,000
+44.53%
|
$60,000
$1.48 P/Share
|
|
Aug 25
2022
|
Andrew D. Ashe |
BUY
Exercise of conversion of derivative security
|
Direct |
95,787
+11.44%
|
$95,787
$1.91 P/Share
|
|
Aug 10
2022
|
Sekar Kathiresan Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-13.59%
|
$1,450,000
$29.9 P/Share
|
|
Aug 10
2022
|
Sekar Kathiresan Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+11.97%
|
$50,000
$1.39 P/Share
|
|
Jul 20
2022
|
Andrew Bellinger Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
20,000
-75.11%
|
$680,000
$34.9 P/Share
|
|
Jul 20
2022
|
Andrew Bellinger Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+42.89%
|
$20,000
$1.39 P/Share
|
|
Jul 19
2022
|
Sekar Kathiresan Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-13.59%
|
$1,450,000
$29.9 P/Share
|
|
Jul 19
2022
|
Sekar Kathiresan Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+11.97%
|
$50,000
$1.39 P/Share
|
|
Jul 13
2022
|
Andrew Bellinger Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-60.14%
|
$240,000
$24.9 P/Share
|
|
Jul 13
2022
|
Andrew Bellinger Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+37.55%
|
$10,000
$1.48 P/Share
|